2022's Fiercest Women in Life Sciences
New Media Department Yu Jie, Duan Yuqing November 17, 2022
We received more than 400 nominations for this year’s list, all describing women who are making strides not only in their scientific fields but also in leveling the metaphorical field to ensure even more women can follow in their footsteps in the decades to come.
Alice Zhang, Verge Genomics
Company: Verge Genomics
Title: Co-founder and CEO
Alice Zhang isn’t your traditional biotech CEO. She’d never held an executive position before Verge but is using inexperience to her advantage—and it’s paying off. Zhang has become one of the few women under the age of 35 to helm a biotech and raise significant venture capital—more than $134 million, in fact.
Anat Ashkenazi, Eli Lilly
Company: Eli Lilly
Title: Chief financial officer
When Anat Ashkenazi graduated college and started her career in traditional financial roles, she didn’t expect to one day be on the executive team at a world-leading drugmaker.
Angela Hwang, Pfizer
Company: Pfizer
Titles: Chief commercial officer and president, global biopharmaceuticals business
Growing up in a Chinese family in South Africa during apartheid made for a challenging upbringing for Angela Hwang. Her family couldn’t live where they wanted, attend public school, take public transportation or vote.
Aviv Regev, Roche
Company: Roche
Titles: Executive vice president at Roche and head of Genentech research and early development
If you were to judge by title alone, Aviv Regev, Ph.D., is a pharma executive. As an executive vice president at Roche and head of Genentech research and early development, she sits on the executive committee of the third largest pharma in the world. But in reality, those titles don’t adequately encompass Regev’s day-to-day work and, more importantly, her impact on the organization.
Celine Martin, Johnson & Johnson
Company: Johnson & Johnson MedTech
Title: Company group chairman, cardiovascular and specialty solutions
Celine Martin has known since 14 that she wanted to transform patients' lives. That desire took her on a 27-year career journey with Johnson & Johnson, both in and out of the U.S.